The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ouaissi, A.
Right arrow Articles by Jeannin, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ouaissi, A.
Right arrow Articles by Jeannin, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Chagas Disease
The Journal of Immunology, 2002, 168: 6366-6374.
Copyright © 2002 by The American Association of Immunologists

The Trypanosoma cruzi Tc52-Released Protein Induces Human Dendritic Cell Maturation, Signals Via Toll-Like Receptor 2, and Confers Protection Against Lethal Infection1

Ali Ouaissi2,*, Eliane Guilvard*, Yves Delneste{dagger}, Gersende Caron{dagger}, Giovanni Magistrelli{dagger}, Nathalie Herbault{dagger}, Nathalie Thieblemont{ddagger} and Pascale Jeannin{dagger}

* Institut de Recherche pour le Développement, Montpellier, France; {dagger} Center d’Immunologie Pierre-Fabre, Saint-Julien en Genevois, France; and {ddagger} Hopital Necker, Paris, France

The intracellular protozoan parasite Trypanosoma cruzi is the etiological agent of Chagas disease. We have recently identified a T. cruzi-released protein related to thiol-disulfide oxidoreductase family, called Tc52, which is crucial for parasite survival and virulence. In vitro, Tc52 in combination with IFN-{gamma} activates human macrophages. In vivo, active immunization with Tc52 relieves the immunosuppression associated to acute infection and elicits a specific immune response. As dendritic cells (DC) have a central role in the initiation of immune responses, we investigated whether Tc52 may modulate DC activity. We show that Tc52 induces human DC maturation. Tc52-treated immature DC acquire CD83 and CD86 expression, produce inflammatory chemokines (IL-8, monocyte chemoattractant protein-1, and macrophage-inflammatory protein-1{alpha}), and present potent costimulatory properties. Tc52 binds to DC by a mechanism with the characteristics of a saturable receptor system and signals via Toll-like receptor 2. While Tc52-mediated signaling involves its reduced glutathione-binding site, another portion of the molecule is involved in Tc52 binding to DC. Finally, we report that immunization with Tc52 protects mice in vivo against lethal infection with T. cruzi. Together these data evidence complex molecular interactions between the T. cruzi-derived molecule, Tc52, and DC, and suggest that Tc52 and related class of proteins might represent a new type of pathogen-associated molecular patterns. Moreover, the immune protection data suggest that Tc52 is among candidate molecules that may be used to design an optimal multicomponent vaccine to control T. cruzi infection.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
V. Schmitz, E. Svensjo, R. R. Serra, M. M. Teixeira, and J. Scharfstein
Proteolytic generation of kinins in tissues infected by Trypanosoma cruzi depends on CXC chemokine secretion by macrophages activated via Toll-like 2 receptors
J. Leukoc. Biol., June 1, 2009; 85(6): 1005 - 1014.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. Rigano, B. Buttari, E. Profumo, E. Ortona, F. Delunardo, P. Margutti, V. Mattei, A. Teggi, M. Sorice, and A. Siracusano
Echinococcus granulosus Antigen B Impairs Human Dendritic Cell Differentiation and Polarizes Immature Dendritic Cell Maturation towards a Th2 Cell Response
Infect. Immun., April 1, 2007; 75(4): 1667 - 1678.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Padilla, D. Xu, D. Martin, and R. Tarleton
Limited Role for CD4+ T-Cell Help in the Initial Priming of Trypanosoma cruzi-Specific CD8+ T Cells
Infect. Immun., January 1, 2007; 75(1): 231 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Koga, S. Hamano, H. Kuwata, K. Atarashi, M. Ogawa, H. Hisaeda, M. Yamamoto, S. Akira, K. Himeno, M. Matsumoto, et al.
TLR-Dependent Induction of IFN-beta Mediates Host Defense against Trypanosoma cruzi
J. Immunol., November 15, 2006; 177(10): 7059 - 7066.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. Monteiro, V. Schmitz, E. Svensjo, R. T. Gazzinelli, I. C. Almeida, A. Todorov, L. B. de Arruda, A. C. T. Torrecilhas, J. B. Pesquero, A. Morrot, et al.
Cooperative Activation of TLR2 and Bradykinin B2 Receptor Is Required for Induction of Type 1 Immunity in a Mouse Model of Subcutaneous Infection by Trypanosoma cruzi
J. Immunol., November 1, 2006; 177(9): 6325 - 6335.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Bafica, H. C. Santiago, R. Goldszmid, C. Ropert, R. T. Gazzinelli, and A. Sher
Cutting Edge: TLR9 and TLR2 Signaling Together Account for MyD88-Dependent Control of Parasitemia in Trypanosoma cruzi Infection
J. Immunol., September 15, 2006; 177(6): 3515 - 3519.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Petersen, K. A. Krumholz, and B. A. Burleigh
Toll-Like Receptor 2 Regulates Interleukin-1{beta}-Dependent Cardiomyocyte Hypertrophy Triggered by Trypanosoma cruzi
Infect. Immun., October 1, 2005; 73(10): 6974 - 6980.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. F. S. Araujo, B. C. G. de Alencar, J. R. C. Vasconcelos, M. I. Hiyane, C. R. F. Marinho, M. L. O. Penido, S. B. Boscardin, D. F. Hoft, R. T. Gazzinelli, and M. M. Rodrigues
CD8+-T-Cell-Dependent Control of Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain after Immunization with Recombinant Proteins Based on Amastigote Surface Protein 2
Infect. Immun., September 1, 2005; 73(9): 6017 - 6025.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
V. Bhatia, M. Sinha, B. Luxon, and N. Garg
Utility of the Trypanosoma cruzi Sequence Database for Identification of Potential Vaccine Candidates by In Silico and In Vitro Screening
Infect. Immun., November 1, 2004; 72(11): 6245 - 6254.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Antoniazi, H. P. Price, P. Kropf, M. A. Freudenberg, C. Galanos, D. F. Smith, and I. Muller
Chemokine Gene Expression in Toll-Like Receptor-Competent and -Deficient Mice Infected with Leishmania major
Infect. Immun., September 1, 2004; 72(9): 5168 - 5174.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Campos, M. Closel, E. P. Valente, J. E. Cardoso, S. Akira, J. I. Alvarez-Leite, C. Ropert, and R. T. Gazzinelli
Impaired Production of Proinflammatory Cytokines and Host Resistance to Acute Infection with Trypanosoma cruzi in Mice Lacking Functional Myeloid Differentiation Factor 88
J. Immunol., February 1, 2004; 172(3): 1711 - 1718.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
V. Michailowsky, K. Luhrs, M. O. C. Rocha, D. Fouts, R. T. Gazzinelli, and J. E. Manning
Humoral and Cellular Immune Responses to Trypanosoma cruzi-Derived Paraflagellar Rod Proteins in Patients with Chagas' Disease
Infect. Immun., June 1, 2003; 71(6): 3165 - 3171.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. R. P. Ferreira, E. F. Abrantes, C. V. Rodrigues, B. Caetano, G. C. Cerqueira, A. C. Salim, L. F. L. Reis, and R. T. Gazzinelli
Identification and characterization of a novel mouse gene encoding a Ras-associated guanine nucleotide exchange factor: expression in macrophages and myocarditis elicited by Trypanosoma cruzi parasites
J. Leukoc. Biol., December 1, 2002; 72(6): 1215 - 1227.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.